An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome. (2012)
Attributed to:
Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome(IBS-D)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.5056/jnm.2012.18.3.258
PubMed Identifier: 22837873
Publication URI: http://europepmc.org/abstract/MED/22837873
Type: Journal Article/Review
Volume: 18
Parent Publication: Journal of neurogastroenterology and motility
Issue: 3
ISSN: 2093-0879